Renaissance Technologies (RenTech)'s PBH Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 96,602 shares of Prestige Consumer Healthcare Inc. (PBH) worth $5.96 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in PBH, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2013, adding 359,600 shares. Largest reduction occurred in Q1 2014, reducing 520,500 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Prestige Consumer Healthcare (PBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Prestige Consumer Healthcare (PBH) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -132,600 | Reduce 57.85% | 96,602 | $61.69 |
| Q3 2025 | -176,602 | Reduce 43.52% | 229,202 | $62.40 |
| Q2 2025 | +37,500 | Add 10.18% | 405,804 | $79.85 |
| Q1 2025 | +60,900 | Add 19.81% | 368,304 | $85.97 |
| Q4 2024 | -20,198 | Reduce 6.17% | 307,404 | $78.09 |
| Q3 2024 | -46,200 | Reduce 12.36% | 327,602 | $72.10 |
| Q2 2024 | +15,100 | Add 4.21% | 373,802 | $68.85 |
| Q1 2024 | +4,700 | Add 1.33% | 358,702 | $72.56 |
| Q4 2023 | -46,200 | Reduce 11.54% | 354,002 | $61.22 |
| Q3 2023 | +43,100 | Add 12.07% | 400,202 | $57.19 |
| Q2 2023 | +17,300 | Add 5.09% | 357,102 | $0.06 |
| Q1 2023 | +7,500 | Add 2.26% | 339,802 | $0.06 |
| Q4 2022 | -18,400 | Reduce 5.25% | 332,302 | $0.06 |
| Q3 2022 | -22,700 | Reduce 6.08% | 350,702 | $49.83 |
| Q2 2022 | +66,300 | Add 21.59% | 373,402 | $58.80 |
| Q1 2022 | -58,800 | Reduce 16.07% | 307,102 | $52.94 |
| Q4 2021 | +112,800 | Add 44.57% | 365,902 | $60.65 |
| Q3 2021 | +32,100 | Add 14.52% | 253,102 | $56.11 |
| Q2 2021 | +28,200 | Add 14.63% | 221,002 | $52.10 |
| Q1 2021 | -151,300 | Reduce 43.97% | 192,802 | $44.08 |
| Q4 2020 | -48,800 | Reduce 12.42% | 344,102 | $34.87 |
| Q3 2020 | -19,100 | Reduce 4.64% | 392,902 | $36.42 |
| Q2 2020 | +347,200 | Add 535.79% | 412,002 | $37.56 |
| Q1 2020 | +64,802 | New Buy | 64,802 | $36.68 |
| Q3 2019 | -29,300 | Sold Out | 0 | $0.00 |
| Q2 2019 | +29,300 | New Buy | 29,300 | $31.67 |
| Q1 2019 | -17,600 | Sold Out | 0 | $0.00 |
| Q4 2018 | -52,600 | Reduce 74.93% | 17,600 | $30.85 |
| Q3 2018 | +70,200 | New Buy | 70,200 | $37.89 |
| Q2 2018 | -37,300 | Sold Out | 0 | $0.00 |
| Q1 2018 | -302,700 | Reduce 89.03% | 37,300 | $33.73 |
| Q4 2017 | +189,100 | Add 125.31% | 340,000 | $44.41 |
| Q3 2017 | -365,600 | Reduce 70.78% | 150,900 | $50.09 |
| Q2 2017 | +30,500 | Add 6.28% | 516,500 | $52.81 |
| Q1 2017 | +94,500 | Add 24.14% | 486,000 | $55.56 |
| Q4 2016 | -288,600 | Reduce 42.43% | 391,500 | $52.10 |
| Q3 2016 | +199,300 | Add 41.45% | 680,100 | $48.27 |
| Q2 2016 | -64,600 | Reduce 11.84% | 480,800 | $55.40 |
| Q1 2016 | +149,300 | Add 37.69% | 545,400 | $53.39 |
| Q4 2015 | +239,700 | Add 153.26% | 396,100 | $51.48 |
| Q3 2015 | +139,100 | Add 804.05% | 156,400 | $45.16 |
| Q2 2015 | +17,300 | New Buy | 17,300 | $46.24 |
| Q1 2014 | -520,500 | Sold Out | 0 | $0.00 |
| Q4 2013 | -141,600 | Reduce 21.39% | 520,500 | $35.80 |
| Q3 2013 | +359,600 | Add 118.88% | 662,100 | $30.12 |
| Q2 2013 | +302,500 | Add 0.00% | 302,500 | $29.14 |
Renaissance Technologies (RenTech)'s Prestige Consumer Healthcare Investment FAQs
Renaissance Technologies (RenTech) first purchased Prestige Consumer Healthcare Inc. (PBH) in Q2 2013, acquiring 302,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Prestige Consumer Healthcare Inc. (PBH) for 46 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to Prestige Consumer Healthcare Inc. (PBH) was in Q3 2013, adding 662,100 shares worth $19.94 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 96,602 shares of Prestige Consumer Healthcare Inc. (PBH), valued at approximately $5.96 M.
As of the Q4 2025 filing, Prestige Consumer Healthcare Inc. (PBH) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Prestige Consumer Healthcare Inc. (PBH) was 680,100 shares, as reported at the end of Q3 2016.